Jan Lemmens

471 total citations
12 papers, 287 citations indexed

About

Jan Lemmens is a scholar working on Genetics, Hematology and Molecular Biology. According to data from OpenAlex, Jan Lemmens has authored 12 papers receiving a total of 287 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 5 papers in Hematology and 4 papers in Molecular Biology. Recurrent topics in Jan Lemmens's work include Acute Myeloid Leukemia Research (3 papers), Lymphoma Diagnosis and Treatment (3 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers). Jan Lemmens is often cited by papers focused on Acute Myeloid Leukemia Research (3 papers), Lymphoma Diagnosis and Treatment (3 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers). Jan Lemmens collaborates with scholars based in Belgium, United States and France. Jan Lemmens's co-authors include Roberto Salgado, Peter A. van Dam, Luc Dirix, Peter Vermeulen, Reinhilde Weytjens, Cécile Colpaert, Ina Benoy, A. Prové, P. Huget and Hans Deckmyn and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Jan Lemmens

11 papers receiving 278 citations

Peers

Jan Lemmens

ONCOL

HEMAT

CCM

Holleh Husseinzadeh United States

N. Eche France

Л. П. Менделеева Russia

Joseph Corkery United States

Piero Maria Stefani Italy

Carmen Julia Tartari Italy

Amy Plotkin United States

Haoxuan Zhong China

Nancy Harold United States

Shalabh Singhal United States

Holleh Husseinzadeh United States

Jan Lemmens

53 ×0.6

ONCOL

74 ×1.0

51 ×0.8

HEMAT

81 ×1.4

CCM

128 ×2.5

Citations per year, relative to Jan Lemmens Jan Lemmens (= 1×) peers Holleh Husseinzadeh

Countries citing papers authored by Jan Lemmens

Since Specialization

Citations

This map shows the geographic impact of Jan Lemmens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Lemmens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Lemmens more than expected).

Fields of papers citing papers by Jan Lemmens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Lemmens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Lemmens. The network helps show where Jan Lemmens may publish in the future.

Co-authorship network of co-authors of Jan Lemmens

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Lemmens. A scholar is included among the top collaborators of Jan Lemmens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Lemmens. Jan Lemmens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Meers, Stef, Koen Theunissen, Koen Van Eygen, et al.. (2024). Real‐life data of luspatercept in lower‐risk myelodysplastic syndromes advocate new research objectives. SHILAP Revista de lepidopterología. 5(5). 1096–1099.

Meers, Stef, Ann De Becker, Kristien Wouters, et al.. (2023). Disease Perception Is Correlated with Health-Related Quality of Life in Patients Suffering from Myelodysplastic Syndromes: Results of the Belgian Be-QUALMS Study. Cancers. 15(13). 3296–3296. 2 indexed citations

Lemmens, Jan, et al.. (2021). Cobalamin and folic acid deficiencies presenting with features of a thrombotic microangiopathy: a case series. Acta Clinica Belgica. 77(4). 787–791. 2 indexed citations

Criel, Maarten, et al.. (2016). Prekallikrein deficiency in a 15-year-old boy with Ménière’s disease: a case report. Acta Clinica Belgica. 72(4). 274–277. 4 indexed citations

Casulo, Carla, Eric D. Jacobsen, Koen Van Eygen, et al.. (2016). Preliminary safety, pharmacokinetics, and pharmacodynamics of duvelisib plus rituximab or obinutuzumab in patients with previously untreated CD20+ follicular lymphoma.. Journal of Clinical Oncology. 34(15_suppl). e19052–e19052. 5 indexed citations

Casulo, Carla, Juan‐Manuel Sancho, Koen Van Eygen, et al.. (2016). Contempo: Preliminary Results in First-Line Treatment of Follicular Lymphoma with the Oral Dual PI3K-δ,γ Inhibitor, Duvelisib, in Combination with Rituximab or Obinutuzumab. Blood. 128(22). 2979–2979. 14 indexed citations

Devos, Timothy, Pierre Zachée, Dominique Bron, et al.. (2014). Myelofibrosis patients in Belgium: disease characteristics. Acta Clinica Belgica. 70(2). 105–111. 6 indexed citations

Vekemans, Marie‐Christiane, Michel Delforge, Chantal Doyen, et al.. (2010). The t(14;20)(q32;q12): a rare cytogenetic change in multiple myeloma associated with poor outcome. British Journal of Haematology. 149(6). 901–904. 8 indexed citations

Meers, Stef, Ahmad Kasran, Louis Boon, et al.. (2007). Monocytes are activated in patients with myelodysplastic syndromes and can contribute to bone marrow failure through CD40–CD40L interactions with T helper cells. Leukemia. 21(12). 2411–2419. 15 indexed citations

10.

Dirix, Luc, Roberto Salgado, Reinhilde Weytjens, et al.. (2002). Plasma fibrin D-dimer levels correlate with tumour volume, progression rate and survival in patients with metastatic breast cancer. British Journal of Cancer. 86(3). 389–395. 165 indexed citations

11.

Paridaens, Robert, Jan Lemmens, Erik Van Limbergen, et al.. (1995). 48 Influence of concomitant radiotherapy on dose intensity of adjuvant CMF in patients with node-positive breast cancer. European Journal of Cancer. 31. S12–S12. 1 indexed citations

12.

Gresele, Paolo, Jef Arnout, W. J. Janssens, et al.. (1984). BM 13.177, A SELECTIVE BLOCKER OF PLATELET AND VESSEL WALL THROMBOXANE RECEPTORS, IS ACTIVE IN MAN. The Lancet. 323(8384). 991–994. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact